Saad Kenderian

Person

Philadelphia, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and materials for treating cancer
- Patent number 12,257,286
- Issue date Mar 25, 2025
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS
- Publication number 20250171547
- Publication date May 29, 2025
- Mayo Foundation for Medical Education and Research
- Cameron DURRANT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATING CANCER
- Publication number 20240384266
- Publication date Nov 21, 2024
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTORS FOR OPTIMIZING IMMUNOTHERAPY
- Publication number 20240158869
- Publication date May 16, 2024
- Kite Pharma, Inc.
- Simone Filosto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20240158467
- Publication date May 16, 2024
- HUMANIGEN, INC.
- Cameron DURRANT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND MATERIALS FOR USING ENGINEERED MESENCHYMAL STEM CELLS T...
- Publication number 20220401488
- Publication date Dec 22, 2022
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS
- Publication number 20220395532
- Publication date Dec 15, 2022
- HUMANIGEN, INC.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20220040229
- Publication date Feb 10, 2022
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MATERIALS FOR TREATING CANCER
- Publication number 20210401886
- Publication date Dec 30, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MATERIALS FOR TREATING CANCER
- Publication number 20210355190
- Publication date Nov 18, 2021
- Saad J. Kenderian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20210284714
- Publication date Sep 16, 2021
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS
- Publication number 20210246215
- Publication date Aug 12, 2021
- Humanigen, Inc.
- Cameron DURRANT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20210214723
- Publication date Jul 15, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. KENDERIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE
- Publication number 20210145881
- Publication date May 20, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20210145830
- Publication date May 20, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIME...
- Publication number 20190336504
- Publication date Nov 7, 2019
- Novartis AG
- Saar Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160096892
- Publication date Apr 7, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20150283178
- Publication date Oct 8, 2015
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Saad Kenderian

Person

Patents Grantslast 30 patents

Methods and materials for treating cancer

EphA3 directed CAR-T cells for treatment of tumors

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using a CLL-1 chimeric antigen receptor

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Patents Applicationslast 30 patents

EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS

TREATING CANCER

FACTORS FOR OPTIMIZING IMMUNOTHERAPY

MATERIALS AND METHODS FOR TREATING CANCER

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

METHODS AND MATERIALS FOR USING ENGINEERED MESENCHYMAL STEM CELLS T...

EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS

MATERIALS AND METHODS FOR TREATING CANCER

METHODS AND MATERIALS FOR TREATING CANCER

METHODS AND MATERIALS FOR TREATING CANCER

MATERIALS AND METHODS FOR TREATING CANCER

EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS

MATERIALS AND METHODS FOR TREATING CANCER

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

MATERIALS AND METHODS FOR TREATING CANCER

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIME...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR